HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 25 February 2013

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  34 papers were listed this time. Here's a few in our areas of research interest:

Refaat T, Choi M, Gaber G, et al. Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer. Am J Clin Oncol. 2013 Feb 5. [Epub ahead of print] PubMed PMID: 23388565.

Hiligsmann M, Ben Sedrine W, Bruyère O, et al. Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis. Osteoporos Int. 2013 Feb 1. [Epub ahead of print] PubMed PMID: 23371359.

Nshimyumukiza L, Durand A, Gagnon M, et al. An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res. 2013 Feb;28(2):383-94. PubMed PMID: 22991210.

photo credit:  Images_of_Money via Flickr Creative Commons